GLYC

GlycoMimetics, Inc. News Headlines

$8.3
*  
0.39
4.49%
Get GLYC Alerts
*Delayed - data as of Jul. 28, 2014  -  Find a broker to begin trading GLYC now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Friday Sector Leaders: Manufacturing, Drugs
7/18/2014 2:07:24 PM - BNK Invest

Sector Update: Health Care
7/18/2014 1:33:31 PM - MT Newswires

Sector Update: Health Care Stocks Following Broader Markets Highers; GlycoMimetics Jumps More Than 10% After Naming Cancer-Specialist to Board
7/18/2014 1:32:37 PM - MT Newswires

GlycoMimetics Up on FDA Agreement on Rivipansel Study - Analyst Blog
7/2/2014 4:50:00 PM - Zacks.com

GlycoMimetics Announces Agreement With FDA On Rivipansel
7/1/2014 9:20:00 AM - RTT News

GlycoMimetics Begins Phase 1 Trial Of GMI-1271 For Blood-Related Cancers
6/19/2014 10:34:00 AM - RTT News

GlycoMimetics To Present At Jefferies Global Conference; Webcast At 10:00 AM ET
6/3/2014 9:00:00 AM - RTT News

U.S. Hot Stocks: Hot Stocks to Watch
5/21/2014 9:15:00 AM - Dow Jones Business News

Sector Update: Healthcare
5/21/2014 8:53:17 AM - MT Newswires

GlycoMimetics Posts Q1 Loss
5/8/2014 12:01:00 PM - RTT News

How GlycoMimetics (GLYC) Stock Stands Out in a Strong Industry - Tale of the Tape
4/11/2014 8:39:01 AM - Zacks.com

GlycoMimetics: A Promising Sickle Cell Disease Play
4/10/2014 9:39:00 AM - Seeking Alpha

Should GlycoMimetics (GLYC) Be On Your Radar Now? - Tale of the Tape
4/10/2014 8:48:01 AM - Zacks.com

Biotechs Dominate IPO Calendar, But Most Post Negative Returns
2/6/2014 11:45:00 AM - Seeking Alpha

Biotechs dominate IPO calendar, but most post negative returns
2/6/2014 9:57:52 AM - Renaissance Capital

U.S. IPO Recap: 20 Companies File Or Set Terms For IPOs
1/14/2014 7:31:00 AM - Seeking Alpha

4 U.S. IPOs Planned For The Week Of Jan. 13
1/14/2014 7:03:00 AM - Seeking Alpha

US IPO Recap: Twenty companies file or set terms for IPOs
1/13/2014 9:26:01 AM - Renaissance Capital

4 US IPOs planned for the week of Jan 13
1/13/2014 8:00:03 AM - Renaissance Capital

GlycoMimetics prices upsized IPO at $8 per share
1/10/2014 8:46:55 AM - Renaissance Capital

GlycoMimetics drops IPO price to $8 and increases shares offered
1/7/2014 9:13:02 AM - Renaissance Capital

Orphan disease biotech GlycoMimetics revives IPO filing, removes original terms
12/20/2013 8:54:07 AM - Renaissance Capital

GlycoMimetics postpones $60 million IPO
11/8/2013 8:12:03 AM - Renaissance Capital

15 U.S. IPOs Planned For The Week Of Nov. 4
11/5/2013 7:57:00 AM - Seeking Alpha

Orphan disease biotech GlycoMimetics sets terms for $60 million IPO
10/28/2013 8:12:38 AM - Renaissance Capital

    • << first
    • < previous
    • 1
    • next >
    • last >>